|
業務類別
|
-- |
|
業務概覽
|
HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The company has developed a product pipeline of five product candidates in-house, covering nine indications in metabolic and digestive diseases among which, five are at clinical-stage. The Core Product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases. |
| 公司地址
| Building D, Guangdong, Floor 9 to 10, Fubao Community, Futian District, Shenzhen-Hong Kong Science and, Shenzhen, CHN, 518112 |
| 電話號碼
| +86 75526626253 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.hightidetx.com |
| 員工數量
| 70 |
|
|
